2018-09-19T11:36:25-07:00 2017-12-31 990 2017-01-01 236434390 THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY WIST 2158989910 3601 Spruce Street Philadelphia PA 191044265 Joseph G Trainor Chief Financial Officer 2154956922 2018-06-01 2017 2022-09-23 18:48:47Z Joseph G Trainor 3601 Spruce Steet Philadelphia PA 191044265 109149000 0 X www.wistar.org X 1892 PA Biomedical research with special expertise in cancer research and vaccine development (immunology). 35 35 387 66 157000 -130000 45213000 59722000 2967000 1097000 861000 7807000 17628000 17479000 66669000 86105000 0 0 0 0 26110000 28346000 0 0 1350000 34411000 43887000 60521000 72233000 6148000 13872000 274280000 306940000 66813000 69829000 207467000 237111000 The mission of the Wistar Institute is to marshal the talents of outstanding scientists through a highly enabled culture of biomedical collaboration and innovation in order to solve some of the world's most challenging and important problems in the field of cancer and immunology, and produce ground-breaking advances in world health. Consistent with a pioneering legacy of leadership in not-for-profit biomedical research and a track-record of life-saving contributions in immunology and cell biology, The Wistar Institute aims to pursue novel and courageous research paths to life science discovery, and to accelerate/potentiate the impact of those discoveries by shortening the path from bench to bedside. 0 0 58716000 1097000 The Wistar Institute recognizes that collaboration is one of its core traditional strengths, which is why the Institute takes a team science based approach to catalyzing new discoveries and helping translate basic scientific findings into next generation therapeutics and diagnostics through meaningful partnerships. Researchers at the Institute operate within the frameworks of the Vaccine & Immunotherapy Center and the Cancer Center. Within the Cancer Center's program cores, researchers benefit from the technical support and instrumentation provided by Wistar's Shared Resources facilities. Wistar's expertise in cancer research, infectious diseases and vaccines, combined with the ability to work with partners to move advances from the laboratory to the clinic as quickly as possible, have led to the marketed vaccines against rubella, rabies and rotavirus. As an NCI-designated cancer center, Wistar's cutting edge research investigations into new targeted therapies and immunotherapies for blood-based cancer and solid tumors are leading to significant insights into the underlying mechanisms of disease biology. Committed to improving health, eradicating disease, and expanding the boundaries of knowledge through research and training, the Institute works collaboratively with its partners to ensure the rapid advancement of biomedical research. 0 0 0 58716000 1 1 0 1 0 0 0 1 0 1 1 1 0 1 1 1 1 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 145 0 1 387 1 1 1 0 0 0 0 1 1 0 0 0 0 X 35 35 1 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR CA CO CT FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV WY X Joseph G Trainor CFO 2154956922 3601 Spruce Street Philadelphia PA 191044265 Elizabeth McKee Anderson Trustee 1 0 X 0 0 0 Douglas S Briggs Trustee 1 0 X 0 0 0 Ira Brind Trustee 1 0 X 0 0 0 Ronald Caplan Trustee 2 0 X 0 0 0 Morton Collins PhD Trustee 1 0 X 0 0 0 Susan B Dillon PhD Trustee 1 0 X 0 0 0 Brian H Dovey Trustee 2 0 X 0 0 0 Daniel K Fitzpatrick CFA Trustee 0.25 0 X 0 0 0 Robert Fox Trustee 2 0 X 0 0 0 John Fry Trustee (Beginning June 2017) 1 0 X 0 0 0 L Patrick Gage PhD Trustee 2 0 X 0 0 0 George W Gephart Trustee (until June 2017) 1 0 X 0 0 0 Joseph A Goldblum Trustee 2 0 X 0 0 0 Richard M Horowitz Trustee - Board Vice Chair 4 0 X X 0 0 0 Herbert Kean MD Trustee 0.25 0 X 0 0 0 Perry A Lerner Trustee 1 0 X 0 0 0 James W Lovett Trustee 1 0 X 0 0 0 Susan S McDonald PhD Trustee 1 0 X 0 0 0 Maida Milone Trustee 1 0 X 0 0 0 Abraham L Morris Trustee 1 0 X 0 0 0 Albert Ominsky Esq Trustee 1 X 0 0 0 Arthur M Pappas Trustee 1 0 X 0 0 0 Vincent Price Trustee (until July 2017) 1 0 X 0 0 0 Wendell Pritchett PhD Trustee (Beginning Sept 2017) 1 0 X 0 0 0 Helen P Pudlin Esq Trustee - Board Chair 1 0 X X 0 0 0 Cavan Redmond Trustee 1 0 X 0 0 0 Samuel V Rhoads Trustee 1 0 X 0 0 0 Robert H Rock Trustee 1 0 X 0 0 0 Gerald B Rorer Trustee 1 0 X 0 0 0 Adele K Schaeffer Trustee 1 0 X 0 0 0 Paul J Schmitt Trustee 1 0 X 0 0 0 Milton S Schneider Trustee 1 0 X 0 0 0 William A Slaughter Esq Trustee 1 0 X 0 0 0 Judith E Soltz Esq Trustee 1 0 X 0 0 0 David V Wachs Trustee 1 0 X 0 0 0 Daniel H Wheeler Trustee 1 0 X 0 0 0 Edward Ziff PhD Trustee 1 0 X 0 0 0 Dario Altieri MD President & CEO, Director of Wistar Cancer Center 55 0 X 546174 0 35100 Jennifer Evans Stacey Esq Vice President, General Counsel, Secretary & Gov 55 0 X 252793 0 51730 Joseph Trainor CPA Chief Financial Officer 55 0 X 201059 0 48090 Anita Pepper PhD Vice President, Institutional Advancement 55 0 X 183275 0 24487 Heather A Steinman PhD VP for Business Develop & E. D. Tech 55 0 X 231552 0 35343 David B Weiner Executive Vice President 55 0 X 316444 0 34700 Luis Montaner Professor Vice President, Scientific Operations 55 0 X 279035 0 50211 Meenhard Herlyn Professor 55 0 X 236548 0 53656 Frank Rauscher Professor 55 0 X 261827 0 33804 David W Speicher Professor 55 0 X 233282 0 50044 Dmitry Gabrilovich Professor 55 0 X 258743 0 57475 3000732 0 474640 58 0 1 0 The Arthur Jackson Company 1500 Market St Suite 19 Philadelphia PA 19103 Janitorial services 577516 Allied Universal Security Services PO Box 828854 Philadelphia PA 191828854 Security services 451917 Wolf Scott Associates Inc 910 E Maint Street Suite 200 Norristown PA 19401 Architecturial services 240302 W H Myers Construction Co 5219 N Lawrence Street Philadelphia PA 19120 Construction services 167617 Howson and Howson LLP 350 Sentry Parkway Building 620 Suite 210 Blue Bell PA 19422 Legal services 137382 12 0 0 642000 0 42139000 16941000 251000 59722000 Research Contract Revenue 541700 1097000 1097000 0 0 0 0 0 0 1097000 2745000 0 0 2745000 0 0 0 0 17427000 0 0 17427000 136000 0 109000 0 27000 0 27000 0 0 27000 27512000 0 22441000 9000 5071000 -9000 5062000 0 0 5062000 249000 642000 485000 -236000 0 -236000 Sale of Specialized Services 541700 157000 0 157000 0 104000 0 0 104000 261000 86105000 1097000 157000 25129000 2143000 1529000 583000 31000 0 19746000 14090000 5372000 284000 2031000 1449000 553000 29000 3051000 2177000 830000 44000 1375000 981000 374000 20000 0 395000 0 395000 0 138000 0 138000 0 77000 0 77000 0 534000 534000 2062000 1544000 19000 499000 136000 0 136000 0 924000 610000 260000 54000 893000 214000 616000 63000 4041000 3612000 401000 28000 385000 276000 76000 33000 1258000 1103000 146000 9000 7211000 6324000 839000 48000 268000 0 268000 0 Subawards 15989000 15989000 0 0 Lab Supplies and Equipment Agreement 9307000 8818000 489000 0 269000 0 61000 208000 72233000 58716000 12167000 1350000 5188000 17823000 15000000 10000000 7834000 6467000 11414000 13490000 0 0 0 0 0 0 129000 129000 714000 1152000 177859000 69238000 108526000 108621000 91940000 110968000 16890000 19716000 0 0 0 0 16645000 18574000 274280000 306940000 7715000 10899000 0 0 1497000 1169000 52173000 52878000 0 0 0 0 5428000 4883000 66813000 69829000 X 160018000 185264000 17674000 20178000 29775000 31669000 207467000 237111000 274280000 306940000 X 13872000 13686000 0 0 0 2086000 X 0 1 X 1 1 1 X 39506000 39654000 45984000 45213000 59722000 230079000 39506000 39654000 45984000 45213000 59722000 230079000 230079000 18284000 20105000 44489000 19500000 20308000 122686000 -27000 -3000 -129000 -133000 -130000 -422000 5000 23000 97000 423000 104000 652000 352995000 14480000 0.65179 0.645 X Schedule A, Part II, Line 8 $17,427,000 royalties, $2,745,000 interest/dividend, and $136,000 rent revenue. Schedule A, Part II, Line 10 $104,000 miscellaneous income (including vendor refunds/rebates). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 77000 0 0 77000 0 Schedule C, Part II-B, Line 1 The Wistar Institute engaged the services of several lobbying firms whose responsibilities are to provide government relations services to The Wistar Institute at the federal and state level with regard to both regulatory and legislative issues. Duties include monitoring and tracking legislation which may be of interest to the Wistar Institute and assisting in finding funding sources for programs. In addition, a number of Wistar staff participate in government affairs advocacy on a fairly regular basis (e.g. visits to Congressional offices to advocate for increases in the NIH budget). We also occasionally ask our board, employees or friends/volunteers to write letters or call their representatives regarding legislation that may impact Wistar. 0 0 X X X 0 43529000 73000 7249000 0 779000 0 50072000 17652000 244000 26513000 0 880000 0 43529000 18352000 129000 19000 0 848000 0 17652000 17076000 1585000 347000 0 656000 0 18352000 13462000 1537000 2563000 0 486000 0 17076000 0.6500 0.26 0.09 0 0 0 685000 685000 0 93317000 32020000 61297000 0 0 0 0 0 81881000 37087000 44794000 0 1976000 131000 1845000 108621000 Alternative Investments 19716000 F 19716000 Beneficial interest in charitable remainder trusts 169000 Beneficial interest in perpetual trusts 18256000 Interest rate swap 149000 18574000 Accrued Pension Expense 4883000 4883000 X 101780000 13686000 0 0 1552000 15238000 86542000 0 -437000 -437000 86105000 72136000 0 0 0 594000 594000 71542000 0 691000 691000 72233000 Schedule D, Part III, Line 1 Collections consist of Family Memorabilia and other artifacts which are not used in the Institute's operations. Schedule D, Part III, Line 4 The Institute's collections constitute a history of medical science in Philadelphia and the history of vaccine development. The museum collections are tied to our deeds of trust and have significant historical value, as Wistar was established as the first independent nonprofit biomedical research Institute in the country. Schedule D, Part V, Line 4 Management determines the prudent use for the endowment funds for general purposes and to support research and training programs as specified by the various endowment programs. Schedule D, Part X, Line 2 The Institute is a non-for-profit institute which has been determined by the Internal Revenue Service to be exempt from federal income taxes under Section 501(c) (3) of the Internal Revenue Code (IRC). The Institute accounts for uncertainties in income taxes in accordance with authoritative guidance, which prescribes a recognition threshold of more-likely-than-not to be sustained upon examination by the appropriate taxing authority. Measurement of the tax uncertainty occurs if the recognition threshold has been met. Management believes that there were no tax uncertainties that met the recognition threshold for the year 2017. Schedule D, Part XI, Line 2d Gain on split-interest agreements = $1,818,000. Change in cash surrender value of life insurance policies = $16,000. Pension-net gain = $144,000. Interest rate swap net gain = $108,000. Investment management fees = -$534,000. Schedule D, Part XI, Line 4b Fundraising event expense = -$485,000. Rental expense = -$109,000. Unrelated business receipts = $157,000. Schedule D, Part XII, Line 2d Fundraising event expenses = $ 485,000 and rental expenses = $109,000. Schedule D, Part XII, Line 4b Investment management fees = $534,000 and unrelated business revenues = $157,000. Central America and the Caribbean 0 0 Investments 14838000 0 0 14838000 1 0 1 0 1 0 Schedule F, Part I, Line 1 Hedge Funds Schedule F, Part IV, Line 3 Although Wistar maintains interests in these foreign corporations and partnerships, its ownership percentage did not meet the threshold for reporting on IRS Form 5471 and 8865. 125 Anniversary Gala 823000 584000 239000 0 0 163000 110000 2000 155000 Women and Science 68000 58000 10000 0 0 3000 24000 1000 27000 0 891000 642000 249000 0 0 166000 134000 3000 182000 485000 -236000 X X X X 0 1 X X X X 0 0 0 0 0 0 0 1 0 Dario Altieri MD President & CEO, Director of Wistar Cancer Center 543852 0 0 0 2322 0 35100 0 0 0 581274 0 David B Weiner Executive Vice President 285708 0 20000 0 10737 0 34700 0 0 0 351145 0 Jennifer Evans Stacey Esq Vice President, General Counsel, Secretary & Gov 242197 0 10000 0 596 0 32200 0 19530 0 304523 0 Heather A Steinman PhD VP for Business Develop & E. D. Tech 184514 0 46865 0 173 0 27857 0 7486 0 266895 0 Joseph Trainor CPA Chief Financial Officer 199689 0 0 0 1370 0 26732 0 21358 0 249149 0 Anita Pepper PhD Vice President, Institutional Advancement 183106 0 0 0 169 0 22866 0 1621 0 207762 0 Luis Montaner Professor Vice President, Scientific Operations 253411 0 25000 0 624 0 29700 0 20511 0 329246 0 Dmitry Gabrilovich Professor 257541 0 0 0 1202 0 35100 0 22375 0 316218 0 Frank Rauscher Professor 228677 0 0 0 33149 0 26130 0 7674 0 295630 0 Meenhard Herlyn Professor 234608 0 0 0 1941 0 33317 0 20339 0 290205 0 David W Speicher Professor 230279 0 0 0 3002 0 32016 0 18029 0 283326 0 Schedule J, Part I, Line 1a Tax Indemnification and gross-up payments - for tuition benefits. discretionary spending account - social club dues for CEO only. All amounts included in taxable compensation Schedule J, Part I, Line 1b Tax Indemnification and gross-up payments - yes written policy provided: social club dues are provided via employment contract with CEO. Schedule J, Part I, Line 7 Non-fixed payments, in the form of bonuses (revenue is not a basis for a bonus), are approved by the board compensation committee. The bonuses are based on performance (including leadership). A Philadelphia Authority for Industrial Development 232237287 2017-12-28 52857000 Capital project financing 0 0 0 B Philadelphia Authority for Industrial Development 232237287 2017-12-28 4500000 Capital project financing line of credit 0 0 0 A 0 0 52857000 0 0 0 255000 0 0 0 52602000 0 2014 1 0 1 1 B 0 0 20000 0 0 0 0 0 0 20000 0 0 0 0 0 1 A 0 0 1 1 0 0 0 0 0 0 1 B 0 0 1 1 0 0 0 0 0 0 1 A 0 0 1 0 1 1 PNC Bank 10 1 0 0 0 1 B 0 0 1 0 1 0 0 0 1 A 1 B 1 X 26 251000 NYSE 0 0 1 0 Schedule M, Part I, Line 9 The number reported in column (b) line 9 is the number of contributions. Form 990, Part VI, Section A, Line 2 Daniel Wheeler (Trustee) and Robert Fox (Trustee) have a family relationship. Robert Fox (Trustee) and Richard Horowitz (Trustee) have a business relationship. Morton Collins (Trustee) and David Weiner (Key Employee) have a business relationship. Form 990, Part VI, Section A, Line 7a The Academy of Natural Sciences at Drexel University and the Wistar Family have the right to designate representation to the Board of Trustees. The University of Pennsylvania approves appointments to the Board of Trustees under the Institute's founding deeds of trust. Form 990, Part VI, Section B, Line 11b The Form 990 is reviewed by controller, external tax accountant, and CFO. After all adjustments are made, a final draft is sent to the senior management for their review. The final draft of the Form 990 is then reviewed with the Audit Committee. Also, prior to submission, the Institute posts a copy to the Board's website and notifies members of its availability for their information. Form 990, Part VI, Section B, Line 12c Covered persons are requested to submit an Annual Disclosure of Potential Conflicts of Interest form which are reviewed by management. Covered persons include the Wistar Institute's trustees, officers, "key employees," and the next 5 highly compensated employees. If an individual has any power or influence to approve or disapprove a contract or transaction proposed to be entered into between the institute and any entity or person having a significant relationship to that individual, that individual has a potential conflict of interest and may not participate in the process leading to the approval or disapproval of the contract or transaction unless underlying facts giving rise to the potential conflict of interest are disclosed and approval for participation is obtained. In the case of the Board of Trustees, no individual with a potential conflict of interest with respect to a contract or transaction or any other conflict of interest may vote to approve or disapprove the contract or transaction. Form 990, Part VI, Section B, Line 15 The Board of Trustees has delegated authority to oversee the compensation paid to the organization's executives to the Executive Evaluation and Compensation Committee made up exclusively of independent members of the board of Trustees. The Committee follows the procedures set forth in the IRS regulations under Section 4958 in making compensation decisions. In particular, the Committee annually conducts a review of executive compensation based on independent compensation survey information. At least every other year, the Committee engages an independent consultant to collect comparative compensation data and provide a written opinion on the reasonableness of the proposed compensation for executives. In 2017, the Committee based its review and approval of proposed compensation on independent data and a reasonableness opinion provided by an independent compensation expert during the year, as well as employee performance assessments and market trend information. The Committee documented its compensation decision in contemporaneous written minutes. Form 990, Part VI, Section C, Line 19 The Institute's governing documents and conflict of interest policy are available on the Institute's website (www.wistar.org). The Institute's financial statements are available upon request. Form 990, Part XI, Line 9 Loss on split-interest agreements: $1,818,000. Change in cash surrender value of life insurance policies: $16,000. Pension net loss:$144,000. Interest rate swap - net gain:$108,000 Issac J Wistar Foundation 3601 Spruce Street Philadelphia PA 19104 232593436 Inactive PA 501 (c) (3) PF N/A 0 Tall Cell Technology L P c/o The Connelly Fdn One Tower Bridge Suite 1450 West Conshohocken PA 19428 232811246 Licensing PA The Wistar Institute of Anatomy and Biology Related 796000 3000 0 1 0.9 Beneficial interest in charitable remainder trust PNC Wealth Management 620 Liberty Avenue Pittsburgh PA 15222 Trust PA PNC Bank T 0 169000 1 0 Beneficial interest in perpetual trusts BNY Mellon Wealth Management 1735 Market Street Philadelphia PA 19103 Trusts PA BNY Mellon Bank T 1660000 16345000 1 0 Beneficial interest in perpetual trusts PNC Institutional Investments 620 Liberty Avenue Pittsburgh PA 15222 Trusts PA PNC Bank T 157000 1911000 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Tall Cell Technology L P a-iii 190000 Cost